Notice of Corporate Officer Changes
March 11, 2024---Santen Pharmaceutical Co., Ltd. announced today the appointment of corporate officers effective from April 1, 2024.
List of Corporate Officers effective April 1, 2024
| Name | New Position | Current Position |
|---|---|---|
| Takeshi Ito* | Representative Director of the Board, President, Chief Executive Officer | Representative Director of the Board, President, Chief Executive Officer |
| Rie Nakajima* | Corporate Officer Chief Operating Officer Head of China Business | Corporate Officer Chief Operating Officer Head of North America Business |
| Ippei Kurihara* | Corporate Officer Head of Japan Business | Corporate Officer Head of Japan Business, Head of Japan Sales and Marketing Division, Head of Marketing Department |
| Marianthi Psaha | Corporate Officer Head of Europe, Middle East and Africa (EMEA) Business | Corporate Officer Head of Europe, Middle East and Africa (EMEA) Business |
| Shinichi Teramachi | Corporate Officer Head of Japan Sales and Marketing Division, Head of Sales Department, Head of Marketing Department | Corporate Officer Head of Sales Department, Japan Sales and Marketing Division |
| Tomoyuki Yoshida (Newly appointed) | Corporate Officer Head of Asia Business | Deputy Head of Asia |
| Yoshinori Watanabe | Corporate Officer Head of Sales and Marketing Division – OTC products | Corporate Officer Head of Sales and Marketing Division – OTC products |
| Reza Haque* | Corporate Officer Head of Ophthalmology Innovation Center | Corporate Officer Head of Ophthalmology Innovation Center |
| Peter Sallstig* | Corporate Officer Chief Medical Officer | Corporate Officer Chief Medical Officer |
| Fumiyasu Ako* | Corporate Officer Chief of Staff to CEO | Corporate Officer Chief of Staff to CEO |
| Ken Araki* | Corporate Officer Global Head of Business Development | Corporate Officer Global Head of Business Development |
| Frank Binder | Corporate Officer Head of Supply Chain Division | Corporate Officer Head of Supply Chain Division |
| Mark Dawson* | Corporate Officer Chief Product Supply Officer | Corporate Officer Chief Product Supply Officer |
| Nobuko Kato | Corporate Officer Chief Communications Officer | Corporate Officer Chief Communications Officer |
| Kazuo Koshiji* | Corporate Officer Chief Financial Officer | Corporate Officer Chief Financial Officer & Chief Risk Officer |
| Mika Masunari* | Corporate Officer General Counsel & Chief Compliance Officer | Corporate Officer General Counsel & Chief Compliance Officer |
| Takahiro Morita | Corporate Officer Global Head of Core Principle & Sustainability | Corporate Officer Global Head of Core Principle & Sustainability |
| Yoko Saiki* | Corporate Officer Global Head of Corporate Strategy | Corporate Officer Global Head of Corporate Strategy |
* Corporate Management Member (CMM)
About Santen
As a specialized company dedicated to eye health, Santen aspires to contribute to the realization of “Happiness with Vision” by providing products and services to patients, consumers, and medical professionals around the world. Since its establishment, and guided by its CORE PRINCIPLE, “Tenki ni sanyo suru,” Santen has been committed to helping people maintain and improve their eye health for more than 130 years. Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people in more than 60 countries and regions worldwide. Santen’s mission is to provide essential and significant value to patients and society in the prevention, diagnosis, and treatment of eye diseases through products and services created from its expertise in the ophthalmology field and from the patient's perspective. To create a future in which as many patients as possible can lead happy and fulfilling lives, Santen is committed to doing its utmost to realize a society in which people around the world can experience “Happiness with Vision.”
For more information, please visit Santen’s website https://www.santen.com/en.
Contact
Corporate Communications Group
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com
Official SNS
